Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.6 - $2.37 $5,872 - $8,697
-3,670 Reduced 17.45%
17,358 $31,000
Q3 2022

Nov 14, 2022

SELL
$2.04 - $4.32 $42,560 - $90,128
-20,863 Reduced 49.8%
21,028 $44,000
Q2 2022

Aug 08, 2022

SELL
$3.02 - $4.56 $426,798 - $644,437
-141,324 Reduced 77.14%
41,891 $168,000
Q1 2022

May 16, 2022

BUY
$3.92 - $7.48 $200,198 - $382,011
51,071 Added 38.65%
183,215 $817,000
Q4 2021

Mar 03, 2022

BUY
$6.7 - $11.38 $885,364 - $1.5 Million
132,144 New
132,144 $0

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $39.8M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.